日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Improving HER2 Diagnostics with Digital Real-Time PCR for Ultrafast, Precise Prediction of Anti-HER2 Therapy Response in Patients with Breast Cancer

利用数字实时PCR技术改进HER2诊断,实现对乳腺癌患者抗HER2治疗反应的超快速、精准预测

Choi, Hee-Joo; Park, Soo Young; Song, Minsik; Chang, Jinhyuk; Kim, YoonSik; Park, Hosub; Cha, Chihwan David; Yang, Sohyeon; Heo, Nam Hun; Song, Min Ji; Kim, Da Sol; Kim, Hayeon; Kim, Minuk; Park, Jae Eun; Lee, Yesung; Ji, EunChae; Chung, Heekyoung; Jeong, Ilecheon; Hong, Mineui; Nam, Jin-Wu; Oh, Mee-Hye; Lee, Ji-Hye; Seol, Jinwoo; Won, Hee-Young; Song, Hyun-Woo; Eom, Jaewon; Lee, Do Young; Ryu, Han Suk; Jang, Si-Hyong; Lee, Jeong-Yeon

DNA Damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status.

曲妥珠单抗德鲁替康在HER2表达和同源重组缺陷状态不同的癌细胞中诱导DNA损伤和核异型性。

Kim So Hyeon, Park Yoonjung, Min Ahrum, Park Hye Yeon, Kim Yu-Jin, Ham Sujin, Koh Jiwon, Kim Seongyeong, Lee Dae-Won, Ryu Han Suk, Kim Jin-Soo, Lee Kyung-Hun, Im Seock-Ah

Human MAIT cells undergo clonal selection and expansion during thymic maturation and aging

人类MAIT细胞在胸腺成熟和衰老过程中经历克隆选择和扩增。

Lee, Myeong-Seok; Park, Suyeong; Choi, Jung-Hwan; Bae, Seon Yong; Ryu, Han Suk; Kim, Min-Sung; Kwak, Jae Gun; Lee, You Jeong

Genome-scale knockout simulation and clustering analysis of drug-resistant breast cancer cells reveal drug sensitization targets

基因组规模敲除模拟和耐药乳腺癌细胞聚类分析揭示了药物增敏靶点

Lim, JinA; Jung, Hae Deok; Park, Soo Young; Jeon, Moonhyeon; Kim, Da Sol; Cho, Ryeongeun; Han, Dohyun; Ryu, Han Suk; Kim, Yoosik; Kim, Hyun Uk

MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancer.

MSN/STAT3 通过 IL-6/LPAR1 配体受体复合物驱动三阴性乳腺癌的干性和化疗耐药性

Lee Cheng Hyun, Park Soo Young, Lee Jae Seok, Kim Da Sol, Kim Ha Yeon, Song Min Ji, Im Seock-Ah, Lee Kyung-Hun, Lee Dae-Won, Nikas Ilias P, Koh Ji Won, Yang So Hyeon, Lee Hyebin, Ryu Han Suk

Harnessing Institutionally Developed Clinical Targeted Sequencing to Improve Patient Survival in Breast Cancer: A Seven-Year Experience

利用机构自主研发的临床靶向测序技术提高乳腺癌患者生存率:七年经验

Koh, Jiwon; Kim, Jinyong; Woo, Go-Un; Yi, Hanbaek; Kwon, So Yean; Seo, Jeongmin; Bae, Jeong Mo; Kim, Jung Ho; Won, Jae Kyung; Ryu, Han Suk; Jeon, Yoon Kyung; Lee, Dae-Won; Kim, Miso; Kim, Tae-Yong; Lee, Kyung-Hun; Kim, Tae-You; Lee, Jee-Soo; Seong, Moon-Woo; Kim, Sheehyun; Lee, Sungyoung; Yun, Hongseok; Song, Myung Geun; Choi, Jaeyong; Kim, Jong-Il; Im, Seock-Ah

A Comparative Analysis of Diagnostic Performance and Cytomorphologic Features Between Newly Developed WellPrep(®) and SurePath™ in Serous Effusion Cytology

新型WellPrep®和SurePath™在浆液性积液细胞学诊断性能和细胞形态学特征的比较分析

Choi, Ji Eun; Jin, Min-Sun; Kim, Da Sol; Nikas, Ilias P; Ryu, Han Suk

Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes

增殖性 CD8+/TCF1+ T 细胞和 CD163+/PD-L1+ 巨噬细胞的不同特征可以以不同的方式预测未经治疗的乳腺癌亚型的复发风险。

Ntostoglou, Konstantinos; Theodorou, Sofia D P; Proctor, Tanja; Nikas, Ilias P; Awounvo, Sinclair; Sepsa, Athanasia; Georgoulias, Vassilis; Ryu, Han Suk; Pateras, Ioannis S; Kittas, Christos

Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System

炎症和癌症诊断挑战:当前生物标志物及未来展望——如何应对消化系统中反应性病变、发育不良病变和癌变病变的鉴别诊断难题

Pateras, Ioannis S; Igea, Ana; Nikas, Ilias P; Leventakou, Danai; Koufopoulos, Nektarios I; Ieronimaki, Argyro Ioanna; Bergonzini, Anna; Ryu, Han Suk; Chatzigeorgiou, Antonios; Frisan, Teresa; Kittas, Christos; Panayiotides, Ioannis G

Quantitative proteomics and immunohistochemistry uncover NT5DC2 as a diagnostic biomarker for papillary urothelial carcinoma

定量蛋白质组学和免疫组织化学揭示NT5DC2可作为乳头状尿路上皮癌的诊断生物标志物

Kim, Jun Yong; Lee, Jae Seok; Han, Dohyun; Nikas, Ilias P; Kim, Hyeyoon; Jung, Minsun; Ryu, Han Suk